Biotech Values

[kei]

$CLDX Mr. Adam Feuerstein, the new street article, mentioned about CLDX ===> ..http://www.thestreet.com/story/13133748/2/biotech-stock-mailbag-biotech-bull-so-insanely-good-it-will-make-you-forget-weeks-pain.html

>>> from the article (CLDX)

Celldex Therapeutics (CLDX - Get Report) is one of the most interesting "ASCO plays" for presentation of final results from the Rintega "ReACT" study in patients with recurrent (previously treated) brain cancer. I covered the details about the Rintega data and the possibility of an earlier-than-expected FDA approval filing in a February Mailbag.